Federal Register Proposed Rule: Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor
Policy FR-2026-13656 · Hospital Outpatient (OPPS)
CriticalCY2027 OPPS/ASC proposed rule expands prior auth for Botulinum Toxin.
LCD L39909: Botulinum Toxin Injections — WPS
Policy LCD-L39909 · Pain Management
HighPrepare for billing changes for botulinum toxin injections.
LCD L35172: Botulinum Toxin Injections — Noridian
Policy LCD-L35172 · Pain Management
HighImportant updates for Botulinum Toxin Injection billing.
LCD L35170: Botulinum Toxin Injections — Noridian
Policy LCD-L35170 · Pain Management
HighNew guidelines on Botulinum Toxin Injections may alter billing.
LCD L39832: Botulinum Toxin Injections — NGS
Policy LCD-L39832 · Pain Management
HighNew LCD on Botulinum Toxin Injections impacts billing.
LCD L39836: Botulinum Toxin Injections — Palmetto GBA
Policy LCD-L39836 · Pain Management
HighNew LCD for Botulinum Toxin Injections effective 02/22/2026
LCD L39857: Botulinum Toxin Injections — CGS
Policy LCD-L39857 · Pain Management
HighNew billing guidelines for Botulinum treatments effective 2026.
Proposed LCD DL39836: Botulinum Toxin Injections — Palmetto GBA
Policy LCD-DL39836 · Pain Management
HighImpact of new LCD on botulinum toxin injections reimbursement.
Proposed LCD DL39909: Botulinum Toxin Injections — WPS
Policy LCD-DL39909 · Pain Management
HighNew LCD may improve reimbursement for Botox injections.
Proposed LCD DL35010: Trigger Point Injections — Novitas
Policy LCD-DL35010 · Pain Management
HighNew LCD on trigger point injections may impact billing.
Proposed LCD DL35172: Botulinum Toxin Injections — Noridian
Policy LCD-DL35172 · Pain Management
HighNew LCD may affect botulinum toxin injection billing.
Proposed LCD DL33912: Trigger Point Injections — First Coast
Policy LCD-DL33912 · Pain Management
HighNew LCD for Trigger Point Injections by First Coast affects billing.
LCD L33949: Botulinum Toxins — CGS
Policy LCD-L33949 · Pain Management
RoutineNew LCD on Botulinum Toxins effective Feb 2025.
LCD L33274: Botulinum Toxins — First Coast
Policy LCD-L33274 · Pain Management
RoutineImportant billing updates for Botulinum Toxins treatment.
LCD L33646: Botulinum Toxins — NGS
Policy LCD-L33646 · Pain Management
RoutineImplementing Botulinum Toxins LCD may affect billing practices.
LCD L34635: Botulinum Toxin Type A & Type B — WPS
Policy LCD-L34635 · Pain Management
RoutineNew LCD on Botulinum Toxin by WPS impacts billing practices.
LCD L33458: Chemodenervation — Palmetto GBA
Policy LCD-L33458 · Pain Management
RoutineNew LCD on Chemodenervation impacts billing for providers.
Proposed LCD DL33274: Botulinum Toxins — First Coast
Policy LCD-DL33274 · Pain Management
HighNew LCD for Botulinum Toxins affects billing and reimbursements.
LCD L38809: Botulinum Toxins — Novitas
Policy LCD-L38809 · Pain Management
RoutinePrepare for Novitas' LCD on Botulinum Toxins effective 11/09/2025.